secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vigil Neuroscience, Inc. (—)
CIK:        0001827087
Form:       8-K
Filed at:   2025-08-05T23:59:59+00:00
Accession:  0001193125-25-173134
Event type: m_and_a
Sentiment:  neutral
Materiality: 1.00
Item codes: 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sanofi completes acquisition of Vigil Neuroscience for $8.00/sh + CVR
---------------------------------------------------------------------

- Merger closed Aug 5, 2025; each share of VIGL converted to $8.00 cash plus one CVR.
- CVR entitles holder to $2.00 per CVR upon first commercial sale of VG-3927 for Alzheimer's.
- Stockholders voted 35,191,885 for, 9,521 against, 133,827 abstain to adopt merger.
- All directors and officers resigned; replaced by designees of Sanofi.
- VIGL common stock trading halted; delisting and deregistration initiated.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1827087/000119312525173134/0001193125-25-173134-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1827087/000119312525173134/d904355d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-173134

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer